Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis

Purpose: Intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents including ranibizumab and aflibercept are used to treat patients with ocular disorders such as neovascular age-related macular degeneration (nAMD); however, the injections are associated with rare instances of...

Descripción completa

Detalles Bibliográficos
Autores principales: Souied, Eric H., Dugel, Pravin U., Ferreira, Alberto, Hashmonay, Ron, Lu, Jingsong, Kelly, Simon P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819836/
https://www.ncbi.nlm.nih.gov/pubmed/26855278
http://dx.doi.org/10.3109/09286586.2015.1090004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819836/
https://www.ncbi.nlm.nih.gov/pubmed/26855278
http://dx.doi.org/10.3109/09286586.2015.1090004

Ejemplares similares